194 related articles for article (PubMed ID: 34290089)
1. Nuclear NAD
Shi X; Jiang Y; Kitano A; Hu T; Murdaugh RL; Li Y; Hoegenauer KA; Chen R; Takahashi K; Nakada D
Sci Adv; 2021 Jul; 7(30):. PubMed ID: 34290089
[TBL] [Abstract][Full Text] [Related]
2. Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration.
Greenwald SH; Brown EE; Scandura MJ; Hennessey E; Farmer R; Du J; Wang Y; Pierce EA
Hum Mol Genet; 2021 May; 30(8):644-657. PubMed ID: 33709122
[TBL] [Abstract][Full Text] [Related]
3. Roles of Nmnat1 in the survival of retinal progenitors through the regulation of pro-apoptotic gene expression via histone acetylation.
Kuribayashi H; Baba Y; Iwagawa T; Arai E; Murakami A; Watanabe S
Cell Death Dis; 2018 Aug; 9(9):891. PubMed ID: 30166529
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis.
Subedi A; Liu Q; Ayyathan DM; Sharon D; Cathelin S; Hosseini M; Xu C; Voisin V; Bader GD; D'Alessandro A; Lechman ER; Dick JE; Minden MD; Wang JCY; Chan SM
Cell Stem Cell; 2021 Oct; 28(10):1851-1867.e8. PubMed ID: 34293334
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.
Jones CL; Stevens BM; Pollyea DA; Culp-Hill R; Reisz JA; Nemkov T; Gehrke S; Gamboni F; Krug A; Winters A; Pei S; Gustafson A; Ye H; Inguva A; Amaya M; Minhajuddin M; Abbott D; Becker MW; DeGregori J; Smith CA; D'Alessandro A; Jordan CT
Cell Stem Cell; 2020 Nov; 27(5):748-764.e4. PubMed ID: 32822582
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Nmnat1 in Skeletal Muscle Leads to the Reduction of NAD
Karim M; Iqbal T; Nawaz A; Yaku K; Nakagawa T
J Nutr Sci Vitaminol (Tokyo); 2023; 69(3):184-189. PubMed ID: 37394423
[TBL] [Abstract][Full Text] [Related]
7. NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Kiss A; Csikos C; Regdon Z; Polgár Z; Virág L; Hegedűs C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445574
[TBL] [Abstract][Full Text] [Related]
8. Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.
Iqbal T; Nawaz A; Karim M; Yaku K; Hikosaka K; Matsumoto M; Nakagawa T
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):89-95. PubMed ID: 36332487
[TBL] [Abstract][Full Text] [Related]
9. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet.
Dong H; Guo W; Yue R; Sun X; Zhou Z
Lab Invest; 2024 Mar; 104(3):100329. PubMed ID: 38237740
[TBL] [Abstract][Full Text] [Related]
11. Nuclear NAD
Sokolov D; Sechrest ER; Wang Y; Nevin C; Du J; Kolandaivelu S
Elife; 2021 Dec; 10():. PubMed ID: 34878972
[TBL] [Abstract][Full Text] [Related]
12. Nmnat1-Rbp7 Is a Conserved Fusion-Protein That Combines NAD+ Catalysis of Nmnat1 with Subcellular Localization of Rbp7.
Chen H; Babino D; Schoenbichler SA; Arkhipova V; Töchterle S; Martin F; Huck CW; von Lintig J; Meyer D
PLoS One; 2015; 10(11):e0143825. PubMed ID: 26618989
[TBL] [Abstract][Full Text] [Related]
13. The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription.
Song T; Yang L; Kabra N; Chen L; Koomen J; Haura EB; Chen J
J Biol Chem; 2013 Jul; 288(29):20908-20917. PubMed ID: 23737528
[TBL] [Abstract][Full Text] [Related]
14. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
15. NAD
Li X; Li Y; Li F; Chen Q; Zhao Z; Liu X; Zhang N; Li H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408818
[TBL] [Abstract][Full Text] [Related]
16. Aerobic and resistance exercise training reverses age-dependent decline in NAD
de Guia RM; Agerholm M; Nielsen TS; Consitt LA; Søgaard D; Helge JW; Larsen S; Brandauer J; Houmard JA; Treebak JT
Physiol Rep; 2019 Jul; 7(12):e14139. PubMed ID: 31207144
[TBL] [Abstract][Full Text] [Related]
17. Subcellular NAMPT-mediated NAD
Wang X; Zhang Z; Zhang N; Li H; Zhang L; Baines CP; Ding S
J Neurochem; 2019 Dec; 151(6):732-748. PubMed ID: 31553812
[TBL] [Abstract][Full Text] [Related]
18. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
19. An Alu-mediated duplication in NMNAT1, involved in NAD biosynthesis, causes a novel syndrome, SHILCA, affecting multiple tissues and organs.
Bedoni N; Quinodoz M; Pinelli M; Cappuccio G; Torella A; Nigro V; Testa F; Simonelli F; ; Corton M; Lualdi S; Lanza F; Morana G; Ayuso C; Di Rocco M; Filocamo M; Banfi S; Brunetti-Pierri N; Superti-Furga A; Rivolta C
Hum Mol Genet; 2020 Aug; 29(13):2250-2260. PubMed ID: 32533184
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs targeting cellular redox homeostasis to eliminate acute myeloid leukemia stem cells.
Costa RGA; Silva SLR; Dias IRSB; Oliveira MS; Rodrigues ACBDC; Dias RB; Bezerra DP
Redox Biol; 2023 Jun; 62():102692. PubMed ID: 37031536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
